Concepedia

Christopher H. Crane

CH

Statistics

Publications

250

Citations

26.7K

H-Index

82

Active since

1962

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

Radiation Oncology Associates

NRG Oncology

University of Maryland, Baltimore

Christopher H. Crane is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and surgical oncology.

ORCID

Publications per year

1962–2024

250

Publications

250

PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer

Andrea Cercek, Melissa Lumish, Jenna Sinopoli et al. · New England Journal of Medicine · 2022 · 1.5K citations · Full text

, , +17

Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

Patrick J. Loehrer, Yang Feng, Higinia R. Cárdenes et al. · Journal of Clinical Oncology · 2011 · 832 citations

, , +7

Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease

Matthew H. G. Katz, Peter W. T. Pisters, Douglas B. Evans et al. · Journal of the American College of Surgeons · 2008 · 820 citations · Full text

, , +13

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

Douglas B. Evans, Gauri R. Varadhachary, Christopher H. Crane et al. · Journal of Clinical Oncology · 2008 · 731 citations

, , +16

Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Andrea Cercek, Campbell S.D. Roxburgh, Paul Strombom et al. · JAMA Oncology · 2018 · 645 citations · Full text

, , +17

1–5 of 250